DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 6Dr. Reddy's Laboratories
02 1Supriya Lifescience
03 32Accord healthcare
04 4Accure Labs
05 2Actavis Inc
06 2Alembic Pharmaceuticals Limited
07 1Almaject
08 2Amneal Pharmaceuticals
09 3Aurobindo Pharma Limited
10 2Ayana Pharma
11 14Baxter Healthcare Corporation
12 5Bayer AG
13 1Bluepharma
14 3Bristol Myers Squibb
15 1CKD Otto Pharma
16 1Central Procurement & Supplies Unit
17 2Cheplapharm Arzneimittel Gmbh
18 2Cipla Medpro South Africa
19 1Copharma Aps
20 1Deva Holding AS
21 3EBEWE Pharma Ges.m.b.H Nfg. KG
22 1Eugia Pharma
23 2Flagship Biotech International Pvt. Ltd
24 1Fresenius Kabi USA
25 2Fresenius SE & Co. KGaA
26 1GLAND PHARMA LIMITED
27 6GetWell Pharmaceutical
28 1Health Biotech
29 1Healthcare Pharmaceuticals
30 5Hikma Pharmaceuticals
31 1Intelliscend
32 1JV Healthcare Limited
33 2Janssen-Cilag
34 2Jodas Expoim Pvt. Ltd
35 2Karo Pharma
36 3Key Oncologics
37 2Lupin Ltd
38 5Naprod Life Sciences
39 2Nishchay Pharmaceuticals Pvt. Ltd.
40 4Oethmaan Biosims
41 1PHARMOBEDIENT
42 1Panacea Biotec Limited
43 2Pfizer Consumer Healthcare
44 32Pfizer Inc
45 13Pharmachemie
46 1Pharmaplan
47 1Powercliff Limited
48 1Prohealth Limited
49 3SEACROSS PHARMACEUTICALS
50 1STADA Arzneimittel
51 1Sagent Pharmaceuticals
52 3Sakar Healthcare
53 8Sandoz B2B
54 1Sanoswiss Uab
55 10Sun Pharmaceutical Industries Limited
56 1Taro Pharmaceutical Industries
57 1Tedec Meiji Farma
58 15Teva Pharmaceutical Industries
59 4TherDose Pharma
60 6Viatris
61 2Vinkem Labs Ltd
62 1Zhejiang Hisun Pharmaceutical
63 2Zydus Lifesciences
01 2Concentrate For Dispersion For Infusion
02 4Concentrate For Infusion Solution
03 25Concentrate For Solution For Infusion
04 4Concentrate to the infusion fluid
05 1Concentrate to the infusion fluid, resolution
06 1Doxorubicin 100Mg 50Ml 1 Units Parenteral Use
07 6Doxorubicin 10Mg 5Ml 1 Units Parenteral Use
08 3Doxorubicin 200Mg 100Ml 1 Units Parenteral Use
09 1Doxorubicin 20Mg 10Ml 1 Units Parenteral Use
10 1Doxorubicin 50Mg 1 Unit Parenteral Use
11 1Doxorubicin 50Mg 2 Units Parenteral Use
12 4Doxorubicin 50Mg 25Ml 1 Units Parenteral Use
13 11INF
14 23INJ
15 16INJECTABLE, LIPOSOMAL;INJECTION
16 38INJECTABLE;INJECTION
17 6INJECTION
18 1Infusion Dispersion
19 4Injectable Solution
20 1Injectable; Injection
21 23Injection
22 5Injection fluid, resolution
23 1Liposomal Injection
24 1Liposome Injection
25 1Liquid Injection
26 2Lyo.Inj
27 2Lyophilised Injection
28 1POI
29 2POWDER FOR SOLUTION
30 3Powder For Concentrate For Solution For Infusion
31 1Powder For Dispersion Concentrate For Infusion
32 1Powder For Injectable Solution
33 3Powder For Solution For Injection
34 1Powder and liquids to concentrate for infusion, liposomaldispersjon
35 2Powder for injection fluid, resolution
36 2SOL
37 6SOLUTION
38 2SUSPENSION
39 15Solution For Injection
40 1Vial
41 16Blank
01 21Allowed
02 7Approved
03 3Authorised
04 8Authorized
05 1Cancelled
06 22DISCN
07 7Deregistered
08 45Generic
09 2Lead Market Dossiers- Approved in US and Under review in EU
10 1Lead Market Dossiers- Filed
11 6Originator
12 7Prescription
13 32RX
14 4Withdrawn
15 78Blank
01 2ADRIAMYCIN PFS
02 8Adriamycin
03 2Adriblastin RD
04 3Adriblastin Solution
05 5Adriblastina
06 1Adriblastina CSV 10mg/5ml
07 1Adriblastina CSV 50mg/25ml
08 1Adriblastina RD 10mg
09 1Adriblastina RD 50mg
10 1CAELYX
11 11Caelyx
12 3Caelyx Pegylated Liposomal
13 1Caelyx pegylated liposomal
14 1Celdoxome Pegylated Liposomal
15 1Cipla Doxorubicin 10
16 1Cipla Doxorubicin 50
17 2DOXIL (LIPOSOMAL)
18 1DOXOPEG
19 4DOXORUBA
20 1DOXORUBICIN
21 1DOXORUBICIN -SOL PCH 10MG
22 1DOXORUBICIN 10mg/5ml FRESENIUS
23 1DOXORUBICIN 50mg/25ml FRESENIUS
24 33DOXORUBICIN HYDROCHLORIDE
25 14DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
26 2DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP
27 1DOXORUBICIN HYDROCHLORIDE INJECTION
28 1DOXORUBICIN INJECTION, BP
29 1DOXORUBICIN-SOL PCH 50MG
30 2DOXOTHER
31 1Doxolip
32 1Doxonish 10
33 1Doxonish 50
34 13Doxorubicin
35 1Doxorubicin "Ebewe" 10mg (5ml vial)
36 1Doxorubicin "Ebewe" 50mg (25ml vial)
37 1Doxorubicin - Pch 10
38 2Doxorubicin ACC
39 11Doxorubicin Accord
40 1Doxorubicin Accord 10mg/5ml
41 1Doxorubicin Accord 50mg/25ml
42 2Doxorubicin Accord liposomal
43 2Doxorubicin Actavis
44 1Doxorubicin Aurovitas
45 1Doxorubicin Copharma
46 4Doxorubicin Ebewe
47 2Doxorubicin Mylan
48 1Doxorubicin Mylan Concentrate For Soln For Inf
49 1Doxorubicin Mylan Pdr/Conc/Soln For Infus
50 1Doxorubicin Pch
51 1Doxorubicin Pch 10 10Mg Vial
52 1Doxorubicin Pch 50
53 1Doxorubicin Rtu
54 1Doxorubicin Rtu 10-5 5Ml
55 1Doxorubicin Rtu 200-100 100Ml
56 1Doxorubicin Rtu 50-25 25Ml
57 4Doxorubicin Sandoz eco
58 1Doxorubicin Sanoswiss
59 1Doxorubicin Stada
60 3Doxorubicin Teva
61 1Doxorubicin hcl faulfing powder vial
62 1Doxorubicin-Hexal 10Mg/5Ml
63 1Doxorubicin-Hexal 50Mg/25Ml
64 4Doxorubicin-Teva
65 5Doxorubicin? Accord 2 mg/ml
66 1Doxorubicina Tedec
67 1Doxred 10 Lyophilized Powder
68 1Doxred 10mg/5ml
69 1Doxred 50 Lyophilized Powder
70 1Doxred 50mg/25ml
71 2Farmiblastina
72 2I-DOX
73 1Kemodoxin
74 6Liposomal Doxorubicin SUN
75 2Myocet
76 2Myocet Liposomal
77 3RUBEX
78 1Ribodoxo
79 1Rubexet 10mg/5ml
80 1Rubexet 200mg/100ml
81 1Rubexet 50mg/25ml
82 1Sopilcin 20 mg/10 ml
83 1TARO-DOXORUBICIN LIPOSOMAL
84 2Zolsketil Pegylated Liposomal
85 29Blank
01 16Australia
02 7Canada
03 35India
04 1Indonesia
05 17Italy
06 7Malta
07 8Moldova
08 13Norway
09 1Portugal
10 37South Africa
11 9Spain
12 14Sweden
13 21Switzerland
14 1Turkey
15 54USA
16 3United Kingdom
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
Dosage Form : INJECTABLE, LIPOSOMAL;INJECTION
Dosage Strength : 20MG/10ML (2MG/ML)
Packaging :
Approval Date : 2017-05-15
Application Number : 208657
Regulatory Info : RX
Registration Country : USA
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 10MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
Dosage Form : INJECTABLE, LIPOSOMAL;INJECTION
Dosage Strength : 50MG/25ML (2MG/ML)
Packaging :
Approval Date : 2017-05-15
Application Number : 208657
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 2MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in US and Under review in EU
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 20MG/10ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in US and Under review in EU
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in US and Under review in EU
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 50MG/25ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in US and Under review in EU
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Sopilcin 20 mg/10 ml
Dosage Form : INF
Dosage Strength : 2mg/ml
Packaging : 10X1mg/ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXIL (LIPOSOMAL)
Dosage Form : INJECTABLE, LIPOSOMAL;INJECTION
Dosage Strength : 20MG/10ML (2MG/ML)
Packaging :
Approval Date : 1995-11-17
Application Number : 50718
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXIL (LIPOSOMAL)
Dosage Form : INJECTABLE, LIPOSOMAL;INJECTION
Dosage Strength : 50MG/25ML (2MG/ML)
Packaging :
Approval Date : 2000-06-13
Application Number : 50718
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RUBEX
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 10MG/VIAL
Packaging :
Approval Date : 1989-04-13
Application Number : 62926
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 10MG/VIAL
Packaging :
Approval Date : 1989-03-17
Application Number : 62921
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 20MG/VIAL
Packaging :
Approval Date : 1989-03-17
Application Number : 62921
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 50MG/VIAL
Packaging :
Approval Date : 1989-03-17
Application Number : 62921
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 10MG/VIAL
Packaging :
Approval Date : 1982-01-01
Application Number : 50467
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 50MG/VIAL
Packaging :
Approval Date : 1982-01-01
Application Number : 50467
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 20MG/VIAL
Packaging :
Approval Date : 1985-05-20
Application Number : 50467
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 150MG/VIAL
Packaging :
Approval Date : 1987-07-22
Application Number : 50467
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 2MG/ML
Packaging :
Approval Date : 1987-12-23
Application Number : 50629
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 200MG/100ML
Packaging :
Approval Date : 1988-05-03
Application Number : 50629
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 150MG/75ML
Packaging :
Approval Date : 2011-03-28
Application Number : 50629
Regulatory Info : DISCN
Registration Country : USA
